Related Experiment Video

Updated: Aug 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K

Lung Cancer Treatment Advances in 2022

Fawzi Abu Rous1, Eric K Singhi2, Arthi Sridhar3

  • 1Department of Internal Medicine, Division of Hematology and Oncology, Henry Ford Health System, Detroit, Michigan, USA.

Cancer Investigation
|August 29, 2022
PubMed

Insights

New lung cancer treatments were presented at the American Society of Clinical Oncology 2022 meeting. Key updates for non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) were discussed.

Area of Science:

  • Oncology
  • Clinical Trials
  • Cancer Therapeutics

Background:

  • The treatment of lung cancer is evolving quickly.
  • Significant advancements were presented at the American Society of Clinical Oncology 2022 (ASCO22) meeting.

Purpose of the Study:

  • To summarize key clinical data from ASCO22 relevant to lung cancer management.
  • To provide updates on early-stage and advanced non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).

Main Methods:

  • Review of clinical trial data presented at ASCO22.
  • Focus on studies with significant updates in lung cancer treatment.

Main Results:

  • New therapeutic strategies for NSCLC, including mutated and non-mutated advanced stages.
  • Updated management approaches for early-stage NSCLC.
  • Recent advances in small cell lung cancer (SCLC) treatment.

Conclusions:

  • The presented data signifies important shifts in the standard of care for lung cancer.
  • Clinicians should consider these ASCO22 updates for optimal patient management.
Keywords:
non-small cell lung cancerEarly-stage lung cancerSmall cell lung cancerTKImetastatic lung canceroncogenes

More Related Videos

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

15.8K
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
496